It was reported that eIF4E is highly phosphorylated and overexpressed in some solid tumors, including NSCLC, prostate cancer, breast cancer, penile squamous cell carcinoma, where eIF4E phosphorylation correlates with poor survival and tumor progression7–9, 11. This evidence concerns the gene EIF4E and Familial prostate cancer.